Pre-rRNA represses gene transcription in the XY body of male germ cells

  1. State Key Laboratory of Gene Expression, School of Life Sciences, Westlake University, Hangzhou, China
  2. Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China
  3. Department of Andrology, Center for Men’s Health, Department of ART, Institute of Urology, Urologic Medical Center, Shanghai Key Laboratory of Reproductive Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Akira Shinohara
    The University of Osaka, Suita/Osaka, Japan
  • Senior Editor
    Adèle Marston
    University of Edinburgh, Edinburgh, United Kingdom

Reviewer #1 (Public review):

The authors show that during prophase I of male meiosis, nucleoli disassemble and nucleolar components relocalize to the sex chromosome (XY) body. They further demonstrate that this process is regulated by the ATR-dependent signaling pathway that mediates meiotic sex chromosome inactivation (MSCI). Pharmacological disruption of pre-rRNA synthesis using the RNA polymerase I inhibitor BMH-21 leads to the recruitment of RNA polymerase II to the sex chromosomes and ectopic expression of sex chromosome-linked genes. These findings uncover a previously unrecognized role for pre-rRNAs in maintaining transcriptional silencing during meiosis. The study employs a combination of cell biology, genetics, and genomics approaches, and the conclusions are supported by compelling, well-organized data.

Comments:

(1) The current study focuses on transcriptional regulation of the sex chromosomes. It would be interesting to know whether perturbation of pre-rRNA synthesis also affects transcription of autosomal genes.

(2) Is ribosome biogenesis still active during prophase I of male meiosis? Additional discussion of the timing and extent of rRNA synthesis at this stage would help place the findings in a broader biological context.

(3) A recent preprint reports active RNA polymerase II-mediated transcription of Y chromosome genes within nucleolus-like bodies (NLBs) during prophase I of meiosis in Drosophila male germ cells (https://doi.org/10.64898/2026.05.20.726666). These findings suggest that the meiotic nucleolus may have species-specific roles in regulating sex chromosome gene expression. It would be valuable for the authors to discuss how their findings compare with these observations and the potential evolutionary implications.

Reviewer #2 (Public review):

Summary:

The authors showed the localization pattern of nucleolus components, including Pre-rRNA, a precursor of rRNAs, changes during meiotic prophase I, particularly with the localization of these nucleolar components to the X-Y body, which shows inactivation of RNA polymerase II transcription, during pachynema. The localization of Pre-rRNA depends on ATR kinase and gammaH2AX. The chemical inhibition of rRNA transcription disrupts the binding of pre-rRNA to the X-Y body and suppresses the inhibition of the RNA polymerase II-mediated transcription on the sex chromosomes.

Strengths:

The cytological analysis, combined with the chemical inhibition, provided solid evidence to support the idea that, together with the remodeling of the nucleolus structure, pre-rRNA is an essential component of sex chromosome inactivation in male mouse meiosis. The role of pre-rRNA in sex chromosome inactivation in male meiosis helps our understanding of how the X-Y body, which would be a biological condensate, would be formed; e.g. for example, this Pre-rRNA may promote phase separation.

Weaknesses:

However, there is limited information on how Pre-rRNA is recruited to only sex chromosomes and how the RNA promotes the inactivation of sex chromosomes. Of course, these will be a target of future study. One major weakness of this paper is a poor description of the results, with fair presentation and interpretation of the data.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation